27/04/2017 - 28/04/2017
This exciting two-day symposium is aimed at reviewing the evidence that synaptic dysfunction is a primary causal factor in most, if not all, neuropsychiatric disorders. We will consider the molecular and genetic evidence for the role of synaptic protein mutations in psychiatric disorders before exploring functional studies in mouse models of schizophrenia, autism, and fragile X.
Ideas about cures for these conditions will be presented by Alcino Silva in his talk entitled “Understanding and treating cognitive disorders” and by Riccardo Brambilla in his talk on “Precision medicine approaches to “cure” synaptic and behavioural deficits in Intellectual Disability and Autism Spectrum Disorders”
A key part of the programme will be the discussion around the talks and in breakout groups, which we hope will foster future collaborations.
For more information, please see the symposium programme.